# iSpecimen Inc. (ISPC) — merger/scheme_of_arrangement [expired]
Source: SEC API (secapi.ai) · situation sit_4e1c05471ec29554aae4 · retrieved 2026-08-12T06:57:28.262Z

## Overview
iSpecimen Inc. is a commercial physical and biological research services company that provides specimen procurement and related services.

On August 5, 2026, iSpecimen Inc. entered into a placement agency agreement with E.F. Hutton & Co. and a securities purchase agreement with investors for a public offering of 996,231 shares of common stock and pre-funded warrants to purchase up to 2,849,923 shares of common stock for an aggregate purchase price of $5,000,000 (or $5,000,285 assuming full exercise of the pre-funded warrants). The offering closed on August 7, 2026. The company paid the placement agent a cash fee of 4.0% of aggregate gross proceeds plus a 1% non-accountable expense allowance. Proceeds are intended for repayment of outstanding liabilities, potential acquisitions, and marketing and advertising services, with the remainder for working capital.

## Terms
- Counterparty: E.F. Hutton & Co. (placement agent); various investors · Deal value: $5.0M · Consideration: cash

## Key dates
- Expired 2026-08-07

## Timeline
- 2026-08-07 · 8-K (0001213900-26-086768): 8-K - iSpecimen Inc. — *iSpecimen Inc. is a commercial physical and biological research services company that provides specimen procurement and related services.* On August 5, 2026, iSpecimen Inc. entered into a placement agency agreement with E.F. Hutton & Co. and a securities purchase agreement with investors for a public offering of 996,231 shares of common stock and pre-funded warrants to purchase up to 2,849,923 shares of common stock for an aggregate purchase price of $5,000,000 (or $5,000,285 assuming full exercise of the pre-funded warrants). The offering closed on August 7, 2026. The company paid the placement agent a cash fee of 4.0% of aggregate gross proceeds plus a 1% non-accountable expense allowance. Proceeds are intended for repayment of outstanding liabilities, potential acquisitions, and marketing and advertising services, with the remainder for working capital.
  https://www.sec.gov/Archives/edgar/data/1558569/0001213900-26-086768.txt

## Citations
- 0001213900-26-086768 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000121390026086768